Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

immunomodulatory

immunomodulatory is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 4
News articles 0
Drug details — immunomodulatory
Class
—
Route
—
Patents
20
Programs
4
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

immunomodulatory is an FDA-listed pharmaceutical active ingredient.

Key facts

INN immunomodulatory

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Adjuvant Immunomodulatory (IM) Therapy Phase 3 · Ultragenyx UK · Mucopolysaccharidosis IIIA
  2. BB2121-MM-003 Phase 3 · Celgene · Multiple myeloma (MM) with at least 2 prior therapies includ
  3. KT-US-679-0788 Phase 3 · Anaxis Pharma · Relapsed/refractory multiple myeloma in patients who have re
  4. Immunomodulatory DC vaccines to target prostate cancer Phase 2 · Shenzhen Second People's · Prostate Cancer Indications

Related patents

Browse patents

  1. US 11993641

    Methods for modulating an immune response

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11958893

    Methods for modulating an immune response

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11767355

    Methods for modulating an immune response

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11702461

    T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11696896

    Immunomodulatory nanoparticle treatment of brain injury

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11479595

    Methods for modulating an immune response

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11104712

    Methods for modulating an immune response

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 2021163596

    IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

    Expires Wed May 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10927161

    Methods for modulating an immune response

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10001483

    Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9717827

    Immunomodulatory materials for implantable medical devices

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8557859

    Immunomodulatory compositions

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8383665

    Immunomodulatory compositions

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8309527

    Immunomodulatory oligonucleotides

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8148340

    Immunomodulatory oligonucleotides

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8114848

    Immunomodulatory oligonucleotides

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 2012029034

    Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents

    Expires Wed Jan 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7208478

    Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 6610661

    Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

    Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6562801

    PpGpp and pppGpp as immunomodulatory agents

    Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is immunomodulatory?

immunomodulatory is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.